je.st
news
Cancer therapy deal with Bristol-Myers Squibb boosts Five Prime drug
2014-11-25 08:34:39| Biotech - Topix.net
Five Prime Therapeutics Inc. snagged a deal with Bristol-Myers Squibb Co. around one of the leading drugs in the emerging class of cancer-fighting drugs known as immune checkpoint inhibitors.
Tags: deal
drug
prime
cancer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|